• 11 July 2011
  • News
  • By

Leveraging on biotech consumables, reagents

Revenue 180 crore*
Invitrogen Bioservices India
MD: Mr Devashish Ohri
Business: Manufacturer and supplier of biotech consumables and instruments
Start-up Year: 2005
Address: First Technology Place, 3 EPIP, Whitefield,
Bangalore - 560066
Tel: +91-80-41785400
Fax: +91-80-41680430
Website: www.invitrogen.com
Having acquired the Applied Biosystem agency business from LabIndia Instruments, Invitrogen has better access to a robust line of products

Life Technologies Corporation, headquartered in California, US, operates in India as Invitrogen Bioservices India, specializing in biotech consumables and benchtop instruments. Invitrogen India commenced operations in 2005 from Bangalore. Having acquired the Applied Biosystems agency business from LabIndia Instruments, Invitrogen has better access to a robust line of products that provide end-to-end solutions, as well as customer and technical service support.

Invitrogen BioServices offers its products and solutions through three key functional divisions: Co-located state-of-the-art facility housing commercial, research and support functions, technology driven R&D and manufacturing operations, and global customer service division.

According to BioSpectrum estimates, company has clocked life sciences sales revenue of 180 crore in 2010-11 as against 140 crore in 2009-10 from its India operations.

In September 2010, Life Technologies signed cell line license agreements with a number of companies from across the world including Indian Immunologicals of Hyderabad to provide rights to its proprietary CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines.

In August 2010, Life Technologies launched its Applied Biosystems 3500 Dx Series Genetic Analyzers, the first CE IVD-marked capillary electrophoresis system for nucleic acid analysis, across Asia Pacific including India.

Mr Devashish Ohri, managing director, Life Technologies South Asia says, “Invitrogen consumables along with Applied Biosystems instruments provide a wide spectrum of solutions to meet customer needs and align with their growth strategy.

The next wave of growth will now come in applied markets relating to biofuels, diagnostics, forensics, agriculture, which according to ABLE could be 25 percent of the total biotech market size.”

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email